Chongqing Precision Biotech Co., Ltd
30 active trials across 4 therapeutic areas
30
Active Trials
29
Phase 1
6
Phase 2
0
Phase 3
4
Therapeutic Areas
Portfolio Concentration: 190% of active trials in Oncology
Oncology
57 active / 58 total
Lung Cancer (General)
9 active
9 total since 2015
Solid Tumor (Advanced)
7 active
7 total since 2015
Gastric Cancer
5 active
5 total since 2015
Colorectal Cancer
5 active
5 total since 2015
ALL
4 active
5 total since 2015
Breast Cancer
4 active
4 total since 2015
Multiple Myeloma
3 active
3 total since 2015
Ovarian Cancer
3 active
3 total since 2015
Cholangiocarcinoma
3 active
3 total since 2015
Hodgkin Lymphoma
2 active
2 total since 2015
Renal Cell Carcinoma
2 active
2 total since 2015
Esophageal Cancer
2 active
2 total since 2015
Non-Hodgkin Lymphoma
2 active
2 total since 2015
AML
2 active
2 total since 2015
Thyroid Cancer
1 active
1 total since 2015
Cervical Cancer
1 active
1 total since 2015
NSCLC
1 active
1 total since 2015
Hematologic Malignancies
1 active
1 total since 2015
Immunology
6 active / 6 total
Rare Disease
4 active / 4 total
Cardiovascular
3 active / 3 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)